DENTSPLY SIRONA Inc (XRAY) Stock Analysis
Verdict: WATCH (do not buy)
Debt covenant amendments and GAAP losses weigh on XRAY, but restructuring savings and 5.8x forward P/E offer a turnaround entry.
Investment score: 45/100
Analysis as of
Is DENTSPLY SIRONA Inc stock worth reviewing? The TradeMates thesis
The TradeMates model rates DENTSPLY SIRONA as WATCH. Valuation appears deeply discounted at 0.5x P/S vs peer median 1.94x, but credit facility covenant amendments and structural dental market softness keep financial risk elevated.
7-factor investment score
- Valuation: 60/100 (weight 20%)
- Financial Health: 25/100 (weight 15%)
- Technical Momentum: 30/100 (weight 15%)
- Earnings Quality: 35/100 (weight 15%)
- Insider Sentiment: 80/100 (weight 10%)
- Analyst Consensus: 50/100 (weight 10%)
- Risk-Adjusted Return: 45/100 (weight 15%)
DENTSPLY SIRONA Inc opportunities and risks
What speaks for XRAY
- Substantial valuation discount on forward earnings
What speaks against XRAY
- Credit covenant vulnerability and debt leverage burden
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| XRAY | n/a | 0.5x | 41.2x | 49.5% | -15.0% | 8.1% |
| HAE | 58.9x | 4.1x | 24.8x | 57.4% | 7.1% | 5.3% |
| MMSI | 36.6x | 3.4x | 15.8x | 49.5% | 9.2% | 3.8% |
| MMED | n/a | 1.6x | 29.1x | 53.8% | -10.2% | -6.2% |
| ICUI | 139.4x | 1.9x | 20.8x | 37.6% | 1.4% | 3.7% |
| QDEL | n/a | 0.4x | n/a | 44.6% | -39.2% | -22.1% |
| Peer median | 36.6x | 1.9x | 20.8x | 49.5% | 1.4% | 3.7% |
Frequently asked questions about DENTSPLY SIRONA Inc (XRAY)
Is XRAY stock a good investment?
The TradeMates model rates DENTSPLY SIRONA Inc as WATCH (do not buy) with an investment score of 45/100. The TradeMates model rates DENTSPLY SIRONA as WATCH. Valuation appears deeply discounted at 0.5x P/S vs peer median 1.94x, but credit facility covenant amendments and structural dental market softness keep financial risk elevated. This is algorithmic model output, not personal investment advice.
Is XRAY stock a buy?
The TradeMates model verdict for XRAY is WATCH (do not buy) with an investment score of 45/100. Treat this as a model signal to review, not a personal buy recommendation.